Medical Innovation Acceleration Act of 2022
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jan 28, 2022)
Medical Innovation Acceleration Act of 2022
This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration.
The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.
What just happenedJan 31, 2022
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJan 28, 2022
- Jan 31, 2022Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 28, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jan 28, 2022IntroReferralIntro-H
Introduced in House
- Jan 28, 2022IntroReferral1000
Introduced in House